טוען...
Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia
Current objectives regarding treatment of acute myeloid leukemia (AML) include achieving complete remission (CR) by clinicopathological criteria followed by interrogation for the presence of minimal/measurable residual disease (MRD) by molecular genetic and/or flow cytometric techniques. Although ad...
שמור ב:
| הוצא לאור ב: | Blood |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society of Hematology
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7225688/ https://ncbi.nlm.nih.gov/pubmed/32232484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019004770 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|